<DOC>
	<DOCNO>NCT00050401</DOCNO>
	<brief_summary>The purpose study find high dose antibiotic ( meropenem , MERREMÂ® I.V . ) , along another drug call aminoglycoside ( different type antibiotic ) effective decrease reduce rate antibiotic resistant Pseudomonas aeruginosa , Acinetobacter ( germ cause pneumonia ) , rate resistance difficult treat germ may cause hospital-acquired pneumonia require mechanical ventilatory support . The study hop show increase amount meropenem administer increase duration infusion ( release drug bloodstream ) , level drug stay target level bloodstream decrease ability difficult treat germ resist , kill , treatment use antibiotic ( meropenem ) antibiotic .</brief_summary>
	<brief_title>Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<criteria>Onset exacerbation pneumonia least 72 hour admission acute care facility onset pneumonia nursing home rehabilitation facility subsequent transfer acute care facility Diagnosis hospitalacquired pneumonia require mechanical ventilatory support Patient Patient 's legal guardian must sign write informed consent study participation , pretreatment , Day 7 bronchoscopy Patients hospitalacquired pneumonia cause pathogen resistant MERREM Patients allergies cephalosporin , penicillin carbapenems Patients take anticonvulsant therapy know seizure disorder Patients lung cancer Patients cystic fibrosis , acquire immune deficiency syndrome ( AIDS ) , neutropenia , active tuberculosis , patient take immunosuppressive therapy preparation follow organ transplant . Patients pregnant breast feed Patients unlikely survive Patients certain infection another area require treatment additional antibiotic Patients underlying condition would make difficult interpret response study drug . Patients part another clinical study 30 day entry study . Patients hypotension ( systolic BP &lt; 85mmHg ) acidosis ( arterial pH &lt; 7.25 serum bicarbonate &lt; 15 mg/dl ) despite attempt fluid resuscitation Patients profound hypoxia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>ventilator-associated</keyword>
	<keyword>nosocomial</keyword>
</DOC>